Please assess the completion status of the following clinical trial:

Trial Title: Impact and Evaluation of the Management of Iron Deficiency With or Without Anemia in Patients With Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years~* Patient with cancer regardless of the location~* Patient with specific treatment (chemotherapy +/- targeted therapy and / or radiotherapy, hormone therapy or surgery)~* Patient with Functional Iron Deficiency or absolute with or without anemia~* Having given written informed consent prior to any procedure related to the study.~Exclusion Criteria:~* Patient in a palliative situation not receiving specific treatment for their cancer~* Patient is willing and able to comply with the protocol for the duration of the study including all scheduled treatment, visits and examinations~* Patient with myeloproliferative disease~* Contraindication to treatments for iron deficiency and / or anemia~* Pregnant woman, parturient or nursing mothers~* Patient has no valid health insurance~* Disorder precluding understanding of trial information or informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm with Ferinject (Type: EXPERIMENTAL): Ferinject will be administered once at inclusion

Based on this trial design, predict the completion outcome and termination type (if applicable).